Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ====== Dual antiplatelet therapy complications ====== Dual [[antiplatelet therapy]] is associated with high early risks of major and [[gastrointestinal bleeding]] that decline after the first month in trial cohorts ((Hilkens NA, Algra A, Kappelle LJ, Bath PM, Csiba L, Rothwell PM, Greving JP; CAT Collaboration. Early time course of major bleeding on antiplatelet therapy after TIA or ischemic stroke. Neurology. 2018 Jan 26. pii: 10.1212/WNL.0000000000004997. doi: 10.1212/WNL.0000000000004997. [Epub ahead of print] PubMed PMID: 29374102. )). ---- It is known that [[stent-assisted coiling]] (SAC) for ruptured [[wide-neck intracranial aneurysm]]s has a good efficacy; however, there is an increased risk of perioperative hemorrhagic complications due to the need for [[dual antiplatelet therapy]] (DAPT). ((H. Roh, J. Kim, H. Bae, K. Chong, J.H. Kim, S.I. Suh, T.H. Kwon, W. Yoon, Comparison of stent-assisted and no-stent coil embolization for safety and effectiveness in the treatment of ruptured intracranial aneurysms, J. Neurosurg. (2019) 1–7)) [[Ventriculoperitoneal shunt complication after dual antiplatelet therapy]]. dual_antiplatelet_therapy_complications.txt Last modified: 2024/06/07 02:51by 127.0.0.1